WO2000024765A8 - Chlamydia antigens and corresponding dna fragments and uses thereof - Google Patents
Chlamydia antigens and corresponding dna fragments and uses thereofInfo
- Publication number
- WO2000024765A8 WO2000024765A8 PCT/CA1999/000992 CA9900992W WO0024765A8 WO 2000024765 A8 WO2000024765 A8 WO 2000024765A8 CA 9900992 W CA9900992 W CA 9900992W WO 0024765 A8 WO0024765 A8 WO 0024765A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- seq
- nos
- dna fragments
- corresponding dna
- chlamydia antigens
- Prior art date
Links
- 241000606161 Chlamydia Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 208000007190 Chlamydia Infections Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU12541/00A AU1254100A (en) | 1998-10-28 | 1999-10-28 | Chlamydia antigens and corresponding DNA fragments and uses thereof |
JP2000578335A JP2002530052A (en) | 1998-10-28 | 1999-10-28 | Chlamydia antigens and corresponding DNA fragments and uses thereof |
CA002348827A CA2348827A1 (en) | 1998-10-28 | 1999-10-28 | Chlamydia antigens and corresponding dna fragments and uses thereof |
MXPA01004291A MXPA01004291A (en) | 1998-10-28 | 1999-10-28 | Chlamydia. |
EP99955602A EP1129202A2 (en) | 1998-10-28 | 1999-10-28 | Chlamydia antigenes and corresponding dna fragments and uses thereof |
Applications Claiming Priority (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10604298P | 1998-10-28 | 1998-10-28 | |
US10603998P | 1998-10-28 | 1998-10-28 | |
US10604498P | 1998-10-28 | 1998-10-28 | |
US10603498P | 1998-10-28 | 1998-10-28 | |
US60/106,044 | 1998-10-28 | ||
US60/106,034 | 1998-10-28 | ||
US60/106,039 | 1998-10-28 | ||
US60/106,042 | 1998-10-28 | ||
US10607498P | 1998-10-29 | 1998-10-29 | |
US10607398P | 1998-10-29 | 1998-10-29 | |
US10608798P | 1998-10-29 | 1998-10-29 | |
US10607298P | 1998-10-29 | 1998-10-29 | |
US60/106,072 | 1998-10-29 | ||
US60/106,074 | 1998-10-29 | ||
US60/106,073 | 1998-10-29 | ||
US60/106,087 | 1998-10-29 | ||
US10658998P | 1998-11-02 | 1998-11-02 | |
US10658798P | 1998-11-02 | 1998-11-02 | |
US10703598P | 1998-11-02 | 1998-11-02 | |
US10658898P | 1998-11-02 | 1998-11-02 | |
US10703498P | 1998-11-02 | 1998-11-02 | |
US60/107,034 | 1998-11-02 | ||
US60/106,589 | 1998-11-02 | ||
US60/107,035 | 1998-11-02 | ||
US60/106,588 | 1998-11-02 | ||
US60/106,587 | 1998-11-02 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2000024765A2 WO2000024765A2 (en) | 2000-05-04 |
WO2000024765A3 WO2000024765A3 (en) | 2000-11-09 |
WO2000024765A8 true WO2000024765A8 (en) | 2001-12-20 |
Family
ID=27584510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA1999/000992 WO2000024765A2 (en) | 1998-10-28 | 1999-10-28 | Chlamydia antigens and corresponding dna fragments and uses thereof |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1129202A2 (en) |
JP (1) | JP2002530052A (en) |
CA (1) | CA2348827A1 (en) |
MX (1) | MXPA01004291A (en) |
WO (1) | WO2000024765A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020094340A1 (en) | 1998-12-01 | 2002-07-18 | Andrew D. Murdin | Chlamydia antigens and corresponding dna thereof |
US7297341B1 (en) | 1998-12-23 | 2007-11-20 | Sanofi Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
US6808713B1 (en) | 1998-12-28 | 2004-10-26 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
ATE417106T1 (en) | 1999-03-12 | 2008-12-15 | Aventis Pasteur | CHLAMYDIA ANTIGENS AND THEIR CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
CA2373021A1 (en) | 1999-05-03 | 2000-11-09 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
JP4667694B2 (en) | 1999-09-20 | 2011-04-13 | サノフィ、パストゥール、リミテッド | Chlamydia antigen and corresponding DNA fragments and uses thereof |
US7807802B2 (en) | 2002-11-12 | 2010-10-05 | Abbott Lab | Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69834194T2 (en) * | 1997-06-23 | 2007-03-29 | Loke Diagnostics Aps | SURFACE EXPERIENCED PROTEINS OF CHLAMYDIA PNEUMONIAE |
CA2307846A1 (en) * | 1997-11-21 | 1999-06-03 | Genset S.A. | Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
-
1999
- 1999-10-28 CA CA002348827A patent/CA2348827A1/en not_active Abandoned
- 1999-10-28 JP JP2000578335A patent/JP2002530052A/en active Pending
- 1999-10-28 EP EP99955602A patent/EP1129202A2/en not_active Withdrawn
- 1999-10-28 WO PCT/CA1999/000992 patent/WO2000024765A2/en not_active Application Discontinuation
- 1999-10-28 MX MXPA01004291A patent/MXPA01004291A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2348827A1 (en) | 2000-05-04 |
JP2002530052A (en) | 2002-09-17 |
WO2000024765A3 (en) | 2000-11-09 |
EP1129202A2 (en) | 2001-09-05 |
MXPA01004291A (en) | 2003-06-09 |
WO2000024765A2 (en) | 2000-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1005540A4 (en) | Ikk-beta proteins, nucleic acids and methods | |
MXPA03002413A (en) | B7-like molecules and uses thereof. | |
AU4778101A (en) | Novel polypeptides, and nucleic acids encoding the same | |
WO2001092308A3 (en) | Cystine-knot polypeptides: cloaked-2 molecules and uses thereof | |
IL140937A0 (en) | Molecules designated ldcam | |
WO1998018932A3 (en) | Novel pesticidal toxins and nucleotide sequences which encode these toxins | |
AU8881201A (en) | Tnf receptor-like molecules and uses thereof | |
WO1998006841A3 (en) | Two human nsp-like proteins | |
WO2002040668A3 (en) | Proteins and dna sequences underlying these proteins used for treating inflammations | |
WO2002030973A8 (en) | The caveolin-1 gene and polypeptide encoded thereby and methods of use thereof | |
CA2294566A1 (en) | Ikk-.alpha. proteins, nucleic acids and methods | |
WO1998031795A3 (en) | Novel human metallothionein | |
WO2000024765A8 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO1998011234A3 (en) | Human protein kinases | |
WO2001042474A3 (en) | Interferon-like molecules and uses thereof | |
MXPA03000979A (en) | C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF. | |
WO2003008441A3 (en) | Moringa seed proteins | |
WO2000032794A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2001059120A3 (en) | Il-17 like molecules and uses thereof | |
EP2270171A3 (en) | Haemophilus influenzae antigens and corresponding DNA fragments | |
GB9416536D0 (en) | Orphan receptor | |
WO1998002456A3 (en) | Human c-type lectin | |
WO1998024896A3 (en) | Muteins of obese protein | |
WO2003044047A3 (en) | Virulence proteins of the genus yersinia and uses thereof | |
WO2001070808A3 (en) | Angiogenesis - associated proteins, and nucleic acids encoding the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2000 12541 Country of ref document: AU Kind code of ref document: A |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12541/00 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2348827 Country of ref document: CA Kind code of ref document: A Country of ref document: CA Ref document number: 2000 578335 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/004291 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 511403 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999955602 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1999955602 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page |
Free format text: REVISED TITLE RECEIVED BY THE INTERNATIONAL BUREAU AFTER COMPLETION OF THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09830446 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999955602 Country of ref document: EP |